Beta Bionics Growth Metrics (2024-2025) | BBNX

Growth Metrics Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
Assets Growth (1y) 35.99%
Assets (QoQ) 125.88%-2.38%0.02%
Capital Expenditures Growth (1y) 72.17%156.91%-31.74%
Capital Expenditures (QoQ) 35.47%241.45%-70.13%24.60%102.15%-9.27%
Cash & Equivalents Growth (1y) 14.55%92.34%169.21%120.15%
Cash & Equivalents (QoQ) -16.92%-40.97%34.17%74.09%39.50%-17.38%9.72%
Cash from Investing Activities Growth (1y) -2,443.30%87.06%-37.76%
Cash from Investing Activities (QoQ) -56.83%361.88%-294.61%-503.88%103.45%53.67%
Cash from Operations Growth (1y) -64.48%-11.09%9.20%
Cash from Operations (QoQ) -0.77%21.44%-48.54%-39.89%31.94%35.79%
EBITDA Margin Growth (1y) -6419.002,331.00642.00
EBITDA Margin (QoQ) 98.003,849.00-3075.00-7291.008,848.002,160.00
EBIT Growth (1y) -97.21%-68.64%-55.26%
EBIT Margin Growth (1y) -3259.00-720.00317.00
EBIT Margin (QoQ) -523.001,261.00193.00-4190.002,017.002,298.00
EBIT (QoQ) -24.66%6.85%-18.77%-42.99%-6.60%14.24%
EBT Growth (1y) -94.92%-56.31%-39.99%
EBT Margin Growth (1y) -2759.00-86.00863.00
EBT Margin (QoQ) -743.001,095.00164.00-3275.001,929.002,044.00
EBT (QoQ) -29.79%5.93%-19.06%-34.09%-4.08%15.75%
Enterprise Value Growth (1y) -7.06%-948.72%-1,816.65%-1,208.20%
Enterprise Value (QoQ) 77.19%40.97%-34.17%-492.50%-123.48%-7.88%8.42%
EPS (Basic) Growth (1y) 55.07%83.54%77.40%
EPS (Basic) (QoQ) -14.49%38.40%-30.05%51.02%58.06%15.38%
EPS (Weighted Average and Diluted) Growth (1y) 55.07%83.54%77.40%
EPS (Weighted Average and Diluted) (QoQ) -14.49%38.40%-30.05%51.02%58.06%15.38%
FCF Margin Growth (1y) -2017.002,041.003,205.00
FCF Margin (QoQ) 1,205.001,620.00-381.00-4460.005,263.002,785.00
Free Cash Flow Growth (1y) -64.73%-17.36%12.88%
Free Cash Flow (QoQ) -1.89%10.14%-29.14%-39.31%27.41%33.29%
Gross Margin Growth (1y) -482.008.00212.00
Gross Margin (QoQ) -195.00-37.00383.00-633.00295.00167.00
Gross Profit Growth (1y) 24.58%54.66%69.61%
Gross Profit (QoQ) 12.26%10.27%31.13%-23.25%39.37%20.92%
Net Cash Flow Growth (1y) 367.51%18.41%-23.42%
Net Cash Flow (QoQ) -101.25%149.24%190.84%-7.17%-161.38%146.21%
Net Income Growth (1y) -94.92%-56.31%-39.99%
Net Income (QoQ) -29.79%5.93%-19.06%-34.09%-4.08%15.75%
Net Income towards Common Stockholders Growth (1y) -94.92%-56.31%-39.99%
Net Income towards Common Stockholders (QoQ) -29.79%5.93%-19.06%-34.09%-4.08%15.75%
Net Margin Growth (1y) -2759.00-86.00863.00
Net Margin (QoQ) -743.001,095.00164.00-3275.001,929.002,044.00
Operating Income Growth (1y) -97.21%-68.64%-55.26%
Operating Income (QoQ) -24.66%6.85%-18.77%-42.99%-6.60%14.24%
Operating Margin Growth (1y) -3259.00-720.00317.00
Operating Margin (QoQ) -523.001,261.00193.00-4190.002,017.002,298.00
Profit After Tax Growth (1y) -130.19%-16.64%-45.94%
Profit After Tax (QoQ) -16.18%32.68%-85.99%-58.25%41.13%15.77%
Property, Plant & Equipment (Net) Growth (1y) 92.89%
Property, Plant & Equipment (Net) (QoQ) 15.47%17.23%14.23%
Return on Assets (QoQ) 4.00-1.00
Return on Capital Employed (QoQ) 4.00-3.00
Return on Equity Growth (1y) -33.00
Return on Equity (QoQ) 4.00-161.00126.00-2.00
Return on Sales Growth (1y) -28.00-1.009.00
Return on Sales (QoQ) -7.0011.002.00-33.0019.0020.00
Revenue Growth (1y) 36.39%54.45%63.14%
Revenue (QoQ) 16.34%11.03%22.36%-13.70%31.74%17.28%
Share-based Compensation Growth (1y) 106.63%220.15%126.62%
Share-based Compensation (QoQ) 10.46%31.82%-21.46%80.67%71.15%-6.69%
Shareholder's Equity Growth (1y) -20.80%246.39%236.35%228.80%
Shareholder's Equity (QoQ) -5.52%-3.21%-3.45%-7.22%227.87%-3.86%-2.28%